Background: Triple-negative breast cancer (TNBC) represents the most aggressive and therapeutically challenging subtype of breast carcinoma, characterized by immune evasion and rapid progression. While immunotherapy has shown promise, resistance remains a critical barrier. This study pioneers the use of single-cell RNA sequencing (scRNA-seq) to construct an atlas of immune-tumor interactions in TNBC, revealing exclusive escape signatures.
Methods: Fresh tumor specimens from 10 treatment-naïve TNBC patients underwent scRNA-seq using the 10x Genomics Chromium platform. We identified and clustered 94,327 individual cells, including tumor, T, B, NK, dendritic, and myeloid populations. Ligand-receptor pair analysis, pathway enrichment, and pseudotime modeling were performed to trace the trajectory of immune suppression.
Results: We identified a rare subset of tumor-infiltrating regulatory dendritic cells (tDCregs) expressing IDO1, PD-L1, and TNFRSF14, which directly inhibited cytotoxic T-cell function. Tumor cells co-expressed MUC1, CEACAM1, and LGALS9, forming an immune checkpoint triad that suppressed T-cell receptor signaling. Notably, a stem-like CD8+ T-cell cluster (CXCL13+PD-1+TCF1+) exhibited a quiescent phenotype enriched in non-responders to checkpoint blockade therapy. Our findings define a spatial and functional immune escape module unique to TNBC.
Conclusion: This is the first study to chart the immune landscape of TNBC at single-cell resolution, unveiling novel immunosuppressive cell subsets and checkpoint axes. Our data provide a blueprint for next-generation immunotherapeutic targets and predictive biomarkers. The integration of spatial transcriptomics is underway to validate these findings and drive personalized immunotherapy for TNBC.
To be updated shortly..
Copyright 2024 Mathews International LLC All Rights Reserved